Trial Profile
Fidaxomicin impact for the management of Clostridium difficile infection in NHS secondary care hospitals in England.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 21 Dec 2015 New trial record
- 12 Dec 2015 Results published in the European Journal of Clinical Microbiology and Infectious Diseases